SCHEMBL20997178

SCHEMBL20997178

CC(C)NC(=O)CCc1cn(C(C)C)nn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 3/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 1/20 0.38
MIF P14174 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
FAAH O00519 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP19A1 P11511 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
HDAC1 Q13547 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25514792 0.85 CCNE1 (0.41) ALDH1A1KDM4EGAAMAPTHTT
SCHEMBL19663382 0.84 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHSD17B10MIF
SCHEMBL26011534 0.82 KMT2A (0.39) HPGDMIFGAAMAPTMEN1
SCHEMBL14434944 0.81 CYP19A1 (0.42) ALDH1A1KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL17324236 0.80 CYP19A1 (0.38) MIFMEN1KMT2ACYP19A1HDAC1
SCHEMBL26225463 0.79 CCNE1 (0.34) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL21152290 0.78 CYP19A1 (0.39) MIFMEN1KMT2ACYP19A1HDAC1
SCHEMBL24618012 0.77 NR2F2 (0.41) HPGDMAPTMEN1KMT2ARAB9A
SCHEMBL22170194 0.76 FOLH1 (0.44) ALDH1A1KDM4EHPGDHSD17B10HDAC1
SCHEMBL23771990 0.74 ALB (0.41) MAPTMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11241502-B2 Stable compositions of pegylated carfilzomib compounds AMGEN INC. (US) 2022-02-08 US disclosed
US-20190142957-A1 STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS AMGEN INC. 2019-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142957-A1 STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS MCL1, PHOSPHO1, PSMB5 ALDH1A1 4129/4885KDM4E 850/4885HPGD 3351/4885
US-11241502-B2 Stable compositions of pegylated carfilzomib compounds MCL1, PHOSPHO1, PSMB5 ALDH1A1 4129/4885KDM4E 850/4885HPGD 3351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.